307 related articles for article (PubMed ID: 14647440)
21. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors.
Kikuchi T; Toyota M; Itoh F; Suzuki H; Obata T; Yamamoto H; Kakiuchi H; Kusano M; Issa JP; Tokino T; Imai K
Oncogene; 2002 Apr; 21(17):2741-9. PubMed ID: 11965547
[TBL] [Abstract][Full Text] [Related]
22. DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.
Yin D; Xie D; Hofmann WK; Zhang W; Asotra K; Wong R; Black KL; Koeffler HP
Mol Carcinog; 2003 Jan; 36(1):23-31. PubMed ID: 12503076
[TBL] [Abstract][Full Text] [Related]
23. O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells.
Lai JC; Wu JY; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Anticancer Res; 2009 Jul; 29(7):2535-40. PubMed ID: 19596925
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
Nagasaka T; Sharp GB; Notohara K; Kambara T; Sasamoto H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2003 Nov; 9(14):5306-12. PubMed ID: 14614014
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
Danam RP; Howell SR; Brent TP; Harris LC
Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
[TBL] [Abstract][Full Text] [Related]
27. Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene.
Qian XC; Brent TP
Cancer Res; 1997 Sep; 57(17):3672-7. PubMed ID: 9288770
[TBL] [Abstract][Full Text] [Related]
28. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
[TBL] [Abstract][Full Text] [Related]
29. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
30. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells.
Ma LC; Kuo CC; Liu JF; Chen LT; Chang JY
Mol Pharmacol; 2008 Aug; 74(2):517-26. PubMed ID: 18492797
[TBL] [Abstract][Full Text] [Related]
32. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
[TBL] [Abstract][Full Text] [Related]
35. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
[TBL] [Abstract][Full Text] [Related]
36. [Promoter hypermethylation of DNA repair gene O6-methylguanine DNA methyltransferase in laryngeal squamous cell carcinoma].
Zhang S; Kong WJ; Liu Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):152-6. PubMed ID: 15283294
[TBL] [Abstract][Full Text] [Related]
37. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
38. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K
Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394
[TBL] [Abstract][Full Text] [Related]
39. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
